BioTheryX | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Data insights

6 August 2024

Nuvalent’s next battleground is HER2

NVL-330 features among the latest crop of industry projects newly into human trials.

Subscribe to BioTheryX